Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows a new revision stamp (v3.6.3) replacing the previous v3.6.2, indicating a minor deployment update.
    Difference
    0.1%
    Check dated 2026-07-04T04:53:42.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.0 to v3.6.2, signaling a new build of the page. The change does not affect the displayed study details or navigation.
    Difference
    0.1%
    Check dated 2026-06-27T02:55:16.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The listing now displays 'No longer looking for participants', signaling that enrollment has ended; additional help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added to guide users.
    Difference
    0.5%
    Check dated 2026-06-12T15:38:55.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, representing a small maintenance update without visible content changes.
    Difference
    0.1%
    Check dated 2026-06-05T08:42:09.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    A new revision label v3.5.4 was added, replacing the previous v3.5.3 to denote a minor build/version update for the page. This reflects maintenance or a status update rather than changes to study information or outcomes.
    Difference
    0.1%
    Check dated 2026-05-15T03:23:14.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3, signaling an updated version of the page documentation. Aside from this metadata update, the page content and structure appear unchanged.
    Difference
    0.1%
    Check dated 2026-04-30T18:38:29.000Z thumbnail image

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.